Paper42440255
Pharmacogenomics in oncology: mutation-targeted therapy and biomarker integration in non-small cell lung cancer.
Shaik MN and 7 others. Clin Transl Oncol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Pharmacogenomics in oncology: mutation-targeted therapy and biomarker integration in non-small cell lung cancer. Papers, record 42440255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42440255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacogenomics in oncology: mutation-targeted therapy and biomarker integration in non-small cell lung cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References116
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39064229 | Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions. | J Clin Med | 2024 | https://conductscience.org/library/papers/39064229 | PubMed |
| 2 | 39157507 | Uniqueness of lung cancer in Southeast Asia. | Lancet Reg Health Southeast Asia | 2024 | https://conductscience.org/library/papers/39157507 | PubMed |
| 3 | 37027426 | Global burden and trends of lung cancer incidence and mortality. | Chin Med J (Engl) | 2023 | https://conductscience.org/library/papers/37027426 | PubMed |
| 4 | 31378236 | Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. | Mayo Clin Proc | 2019 | https://conductscience.org/library/papers/31378236 | PubMed |
| 5 | 38334998 | Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South Korea. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/38334998 | PubMed |
| 6 | 42417444 | Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. | CA Cancer J Clin | 2026 | https://conductscience.org/library/papers/42417444 | PubMed |
| 7 | 33569332 | Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival. | Transl Lung Cancer Res | 2021 | https://conductscience.org/library/papers/33569332 | PubMed |
| 8 | 34673888 | Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/34673888 | PubMed |
| 9 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 10 | 35946203 | A clinicoepidemiological profile of lung cancers in India - Results from the National Cancer Registry Programme. | Indian J Med Res | 2022 | https://conductscience.org/library/papers/35946203 | PubMed |
| 11 | 23835165 | Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin. | Clin Lung Cancer | 2013 | https://conductscience.org/library/papers/23835165 | PubMed |
| 12 | 40075634 | KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075634 | PubMed |
| 13 | 39941808 | Heterogeneity in Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941808 | PubMed |
| 14 | 21270786 | CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. | Clin Pharmacol Ther | 2011 | https://conductscience.org/library/papers/21270786 | PubMed |
| 15 | 23988873 | Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. | Clin Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23988873 | PubMed |
| 16 | 23470965 | Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23470965 | PubMed |
| 17 | 20205661 | Pharmacogenetics in oncology: a promising field. | Curr Pharm Des | 2010 | https://conductscience.org/library/papers/20205661 | PubMed |
| 18 | 20824020 | Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer. | Breast Care (Basel) | 2008 | https://conductscience.org/library/papers/20824020 | PubMed |
| 19 | 31564718 | Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. | Br J Cancer | 2019 | https://conductscience.org/library/papers/31564718 | PubMed |
| 20 | 28919011 | Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/28919011 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| RET | 5979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
| ROS1 | 6098 | PubTator's text mining | https://conductscience.org/library/genes/6098 | NCBI Gene |
| SLTM | 79811 | PubTator's text mining | https://conductscience.org/library/genes/79811 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42440255
GET https://conductscience.org/api/papers/v1/42440255/references?page=2